Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo.
暂无分享,去创建一个
Yoshihiro Morikawa | Takeshi Imamura | Ryozo Nagai | Kohei Miyazono | Yasushi Imai | Ichiro Manabe | Issei Komuro | Koji Maemura | I. Komuro | K. Miyazono | T. Imamura | T. Kitamura | R. Nagai | I. Manabe | K. Maemura | Y. Imai | Toshio Kitamura | T. Nosaka | Hidetoshi Kumagai | T. Hisaoka | Y. Morikawa | Tetsuya Nosaka | Yuichi Ikeda | Yuichi Ikeda | Tomoko Hisaoka | Takashi Nakaoka | T. Nakaoka | H. Kumagai
[1] J. Isner,et al. Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions. , 1992, The Journal of clinical investigation.
[2] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[3] R. Virmani,et al. Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Kajava. Structural diversity of leucine-rich repeat proteins. , 1998, Journal of molecular biology.
[5] R. Derynck,et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Iozzo. The Biology of the Small Leucine-rich Proteoglycans , 1999, The Journal of Biological Chemistry.
[7] A. Mui,et al. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.
[8] M. Aoki,et al. Ribozyme Oligonucleotides Against Transforming Growth Factor-&bgr; Inhibited Neointimal Formation After Vascular Injury in Rat Model: Potential Application of Ribozyme Strategy to Treat Cardiovascular Disease , 2000, Circulation.
[9] G. Owens,et al. Recruitment of Serum Response Factor and Hyperacetylation of Histones at Smooth Muscle–Specific Regulatory Regions During Differentiation of a Novel P19-Derived In Vitro Smooth Muscle Differentiation System , 2001, Circulation research.
[10] T. Honjo,et al. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. , 1993, Science.
[11] T. Kitamura,et al. A signal sequence trap based on a constitutively active cytokine receptor , 1999, Nature Biotechnology.
[12] M. Reidy,et al. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[13] A. Goddard,et al. Selection for genes encoding secreted proteins and receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Heagerty,et al. Adenovirus-Mediated Gene Transfer of a Secreted Transforming Growth Factor-&bgr; Type II Receptor Inhibits Luminal Loss and Constrictive Remodeling After Coronary Angioplasty and Enhances Adventitial Collagen Deposition , 2001, Circulation.
[15] R. Ross,et al. The smooth muscle cell in culture. , 1979, Physiological reviews.